MSD to Acquire Privately Held Antelliq Group Establishes MSD Animal Health as a Leader in Emerging Digital Tracking, Traceability and Monitoring Technology Complements MSD Animal Health Portfolio of Vaccines and Pharmaceuticals
KENILWORTH, N.J., & VITRÉ, FRANCE, Dec. 14, 2018 – MSD (tradename of Merck & Co., Inc., Kenilworth, N.J., USA (NYSE: MRK)), and privately held Antelliq Group today announced that the companies have signed a definitive agreement under which MSD will acquire Antelliq from funds advised by BC Partners. Antelliq will be a wholly owned and […]